Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(21/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(21/week)
News
United States
(626/week)
Manufacturing
(444/week)
Energy
(347/week)
Technology
(486/week)
Other Manufacturing
(371/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Transitional cell carcinoma
Apr 15, 2020
FDA Approves First Therapy for Treatment of Low-Grade Upper Tract Urothelial Cancer
Apr 09, 2020
EMD Serono and Pfizer Receive US FDA Breakthrough Therapy Designation and Submit Application for BAVENCIO® for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma
Feb 10, 2020
Seattle Genetics and Astellas Announce Updated Results from Phase 1b/2 Trial of PADCEV(TM) (enfortumab vedotin-ejfv) in Combination with Immune Therapy Pembrolizumab as Investigational First-Line Treatment for Advanced Bladder Cancer
Dec 02, 2019
Seattle Genetics and Astellas Announce Clinical Trial Collaboration with Merck to Evaluate Enfortumab Vedotin in Combination with KEYTRUDA® (pembrolizumab) in Patients with Metastatic Urothelial Cancer
Nov 11, 2019
Global Urothelial Carcinoma Market Insights, Epidemiology and Market Forecasts Report 2019-2028
Sep 28, 2019
Seattle Genetics and Astellas Announce Results from Phase 1 Trial of Investigational Agent Enfortumab Vedotin in Combination with Immune Therapy Pembrolizumab as First-Line Treatment for Advanced Bladder Cancer
Sep 16, 2019
Seattle Genetics and Astellas Announce U.S. FDA Grants Priority Review for Enfortumab Vedotin Biologics License Application in Locally Advanced or Metastatic Urothelial Cancer
Jul 16, 2019
Astellas and Seattle Genetics Announce Submission of Biologics License Application to FDA for Enfortumab Vedotin for Patients with Locally Advanced or Metastatic Urothelial Cancer
Jun 04, 2019
RemeGen, Ltd. Announces Positive Results from RC48 Clinical Trial in HER2-Positive Metastatic or Unresectable Urothelial Cancer
Jun 03, 2019
Astellas and Seattle Genetics Announce Antibody-Drug Conjugate Enfortumab Vedotin Produced Tumor Response Rate of 44 Percent in Patients with Most Common Type of Advanced Urothelial (Bladder) Cancer
May 03, 2019
The Italian R&D Excellence at the American Urological Association's 2019 Annual Meeting
Apr 12, 2019
BALVERSA(TM) (erdafitinib) Receives U.S. FDA Approval for the Treatment of Patients with Locally Advanced or Metastatic Urothelial Carcinoma with Certain FGFR Genetic Alterations
Mar 28, 2019
Seattle Genetics and Astellas Announce Positive Topline Results from Pivotal Trial of Enfortumab Vedotin in Locally Advanced or Metastatic Urothelial Cancer
Feb 11, 2019
Nektar Therapeutics to Webcast Conference Call with Urothelial Cancer Specialist for Analysts & Investors at the 2019 ASCO Genitourinary Cancers Symposium
Jan 23, 2019
Nucleix Announces Initial Positive Results in Detection of Upper Tract Urothelial Carcinoma With Its Bladder EpiCheck Urine Test
Oct 31, 2018
Worldwide Urothelial Cancer Drugs Market Size, Share & Trends Analysis Report (2018-2023) by Treatment Class (Chemotherapy, Immunotherapy)
Oct 30, 2018
Urothelial Cancer Drugs Market Size Worth $3.6 Billion By 2023: Grand View Research, Inc.
Jun 03, 2018
Astellas and Seattle Genetics Present at ASCO 2018 on Enfortumab Vedotin in Patients with Locally Advanced or Metastatic Urothelial Cancer Previously Treated with Checkpoint Inhibitor Therapy
Jun 03, 2018
Erdafitinib Phase 2 Study Results Show Promise in the Treatment of Metastatic Urothelial Cancer
May 24, 2018
Cxbladder(TM) Monitor Demonstrates Clinical Utility In Patients Being Monitored For Recurrent Bladder Cancer (UC)
Page 1
››
Latest News
May 5, 2024
California American Water celebrates Drinking Water Week and 50th anniversary of Safe Drinking Water Act
May 5, 2024
Paradise Greens Named #1 in Arizona for Artificial Grass Installation by Ranking Arizona 2024 Directory
May 5, 2024
BrainChip and Frontgrade Gaisler to Augment Space-Grade Microprocessors with AI Capabilities
May 5, 2024
Niger receives new Russian advisors, equipment
May 5, 2024
Top Afghan diplomat in India quits after $2m gold smuggling reports
May 5, 2024
Teijin Automotive Technologies Celebrates Opening of Huntington, Indiana, Facility Expansion
May 4, 2024
Berkshire Hathaway Inc. First Quarter 2024 Earnings Release
May 4, 2024
How to Prevent Heatstroke at Your Business with Airrex and PortaCool.
View all News
Agenda
29
October
United Kingdom
Copthorne Tara Hotel, London, UK
International Dismounted Soldier, 29-30 October 2024, Copthorne Tara Hotel, London, UK
Navigating the Evolving Battlespace: Enhancing the Capabilities of the Dismounted Soldier The modern battlefield...
24
September
United Kingdom
Hilton London Syon Park, London, UK
Defence Transformation Conference, 24-26 September 2024, Hilton London Syon Park, London, UK
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
View All Events